AMRZ Stock Analysis: Amrize | NYSE

Building Materials | NYSE, USA | Market Cap: 20.378m USD | 12M Return: -24.5% | CH1430134226 | Charts, Fundamentals & Technical Analysis

Cement, Aggregates, Roofing, Insulation
Total Rating 33
Safety 63
Buy Signal -0.98
Building Materials
Industry Rotation: -2.5
Market Cap: 20.4B
Avg Turnover: 144M
Risk 3d forecast
Volatility34.9%
VaR 5th Pctl6.21%
VaR vs Median7.96%
Reward TTM
Sharpe Ratio-0.69
Rel. Str. IBD5.1
Rel. Str. Peer Group9.4
Character TTM
Beta1.213
Beta Downside1.513
Hurst Exponent0.506
Drawdowns 3y
Max DD44.06%
CAGR/Max DD-0.53
CAGR/Mean DD-1.66
EPS (Earnings per Share) EPS (Earnings per Share) of AMRZ over the last years for every Quarter: "2021-12": null, "2022-12": null, "2023-12": null, "2024-03": null, "2024-06": null, "2024-09": null, "2024-12": null, "2025-03": -0.14, "2025-06": 0.78, "2025-09": 1.13, "2025-12": 0.62, "2026-03": -0.21, "2026-06": 0.88,
Last SUE: -0.24
Qual. Beats: 0
Revenue Revenue of AMRZ over the last years for every Quarter: 2021-12: 8132, 2022-12: 10726, 2023-12: 2914, 2024-03: 2166, 2024-06: 3243, 2024-09: 3446, 2024-12: 2849, 2025-03: 2081, 2025-06: 3220, 2025-09: 3675, 2025-12: 2839, 2026-03: 2178, 2026-06: 3494,
Rev. CAGR: 0.59%
Rev. Trend: 94.4%
Last SUE: 1.19
Qual. Beats: 1

Warnings

Below Avwap Earnings
Below Sma 200d

Tailwinds

No distinct edge detected

Seasonality 1.3 years of data

Jan - -
Feb - -
Mar - -
Apr - -
May - -
Jun -2.4% -
Jul -7.0% -
Aug -8.3% -
Sep - -
Oct - -
Nov - -
Dec - -

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: AMRZ Amrize

Amrize AG (NYSE: AMRZ) is a Swiss-domiciled building solutions provider serving infrastructure, commercial, and residential construction markets across North America and Canada. The company operates through two segments: Building Materials, which supplies cement, aggregates, ready-mix concrete, asphalt, and related construction inputs, and Building Envelope, which provides roofing and wall systems such as single-ply membranes, insulation, shingles, sheathing, waterproofing, protective coatings, adhesives, tapes, and sealants. Originally incorporated as Holcim North America Finance Ltd, the entity was renamed Amrize AG in December 2013 and was re-incorporated in 2023, with its headquarters in Zug, Switzerland.

The company debuted on public markets following its June 2025 IPO and is classified within the Materials sector under the Construction Materials sub-industry. As a large-cap issuer with a market capitalization of roughly $20.9 billion, Amrizes vertically integrated model spans upstream materials production (cement and aggregates) and downstream building components, a structure common among North American construction materials peers seeking exposure across the full project lifecycle.

Headlines to Watch Out For
  • US infrastructure bill funding accelerates cement and aggregates demand
  • Housing starts decline pressures building envelope product volumes
  • Energy cost volatility squeezes cement and asphalt margins
Piotroski VR-10 (Strict) 5.5
Net Income: 1.21b TTM > 0 and > 6% of Revenue
FCF/TA: 0.05 > 0.02 and ΔFCF/TA 0.54 > 1.0
NWC/Revenue: 3.53% < 20% (prev 10.20%; Δ -6.67% < -1%)
CFO/TA 0.09 > 3% & CFO 2.18b > Net Income 1.21b
Net Debt (7.05b) to EBITDA (2.84b): 2.48 < 3
Current Ratio: 1.10 > 1.5 & < 3
Outstanding Shares: last quarter (553.6m) vs 12m ago 0.09% < -2%
Gross Margin: 25.03% > 18% (prev 25.93%; Δ -0.90% > 0.5%)
Asset Turnover: 50.37% > 50% (prev 48.76%; Δ 1.61% > 0%)
Interest Coverage Ratio: 5.68 > 6 (EBIT TTM 1.89b / Interest Expense TTM 333.0m)
Altman Z'' 1.92
A: 0.02 (Total Current Assets 4.58b - Total Current Liabilities 4.15b) / Total Assets 24.6b
B: 0.04 (Retained Earnings 997.0m / Total Assets 24.6b)
C: 0.08 (EBIT TTM 1.89b / Avg Total Assets 24.2b)
D: 1.09 (Book Value of Equity 12.9b / Total Liabilities 11.7b)
Altman-Z'' = 1.92 = BBB
Beneish M -2.96
DSRI: 1.03 (Receivables 2.06b/1.89b, Revenue 12.2b/11.6b)
GMI: 1.04 (GM 25.93% / 25.03%)
AQI: 0.96 (AQ_t 0.45 / AQ_t-1 0.47)
SGI: 1.05 (Revenue 12.2b / 11.6b)
TATA: -0.04 (NI 1.21b - CFO 2.18b) / TA 24.6b)
Beneish M = -2.96 (Cap -4..+1) = A
What is the price of AMRZ shares?

As of October 09, 2026, the stock is trading at USD 36.50 with a total of 3,152,351 shares traded. Over the past week, the price has changed by -2.01%, over one month by -12.99%, over three months by -26.01% and over the past year by -24.51%.

Current recommended Stop Loss: 35.00 (which is 4.1% or 1.4 ATR below the current price).

Is AMRZ a buy, sell or hold?

Amrize has received a consensus analysts rating of 3.67. Therefore, it is recommended to hold AMRZ.

  • StrongBuy: 7
  • Buy: 2
  • Hold: 10
  • Sell: 2
  • StrongSell: 0

What are the forecasts/targets for the AMRZ price?
Analysts Target Price 50.9 39.5%
Amrize (AMRZ) - Fundamental Data Overview as of 06 October 2026
Market Cap USD = 20.4b (20.4b USD * 1.0 USD.USD)
P/E Trailing = 16.7085
P/E Forward = 13.4409
P/S = 1.6727
P/B = 1.6111
P/EG = 1.0362
Revenue TTM = 12.2b USD
EBIT TTM = 1.89b USD
EBITDA TTM = 2.84b USD
Long Term Debt = 4.24b USD (from longTermDebt, last quarter)
Short Term Debt = 1.90b USD (from shortTermDebt, last quarter)
Debt = 7.78b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.15b
Net Debt = 7.05b USD (calculated: Debt 7.78b - CCE 729.0m)
Enterprise Value = 27.4b USD (20.4b + Debt 7.78b - CCE 729.0m)
Interest Coverage Ratio = 5.68 (Ebit TTM 1.89b / Interest Expense TTM 333.0m)
EV/FCF = 20.77x (Enterprise Value 27.4b / FCF TTM 1.32b)
FCF Yield = 4.82% (FCF TTM 1.32b / Enterprise Value 27.4b)
FCF Margin = 10.84% (FCF TTM 1.32b / Revenue TTM 12.2b)
Net Margin = 9.89% (Net Income TTM 1.21b / Revenue TTM 12.2b)
Gross Margin = 25.03% ((Revenue TTM 12.2b - Cost of Revenue TTM 9.14b) / Revenue TTM)
Gross Margin QoQ = 28.42% (prev 9.69%)
Tobins Q-Ratio = 1.11 (Enterprise Value 27.4b / Total Assets 24.6b)
Interest Expense / Debt = 4.28% (Interest Expense 333.0m / Debt 7.78b)
Taxrate = 23.53% (369.0m / 1.57b)
NOPAT = 1.45b (EBIT 1.89b * (1 - 23.53%))
Current Ratio = 1.10 (Total Current Assets 4.58b / Total Current Liabilities 4.15b)
Debt / Equity = 0.61 (Debt 7.78b / totalStockholderEquity, last quarter 12.9b)
Debt / EBITDA = 2.48 (Net Debt 7.05b / EBITDA 2.84b)
Debt / FCF = 5.34 (Net Debt 7.05b / FCF TTM 1.32b)
Total Stockholder Equity = 13.0b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.98% (Net Income 1.21b / Total Assets 24.6b)
RoE = 9.25% (Net Income TTM 1.21b / Total Stockholder Equity 13.0b)
RoCE = 10.95% (EBIT 1.89b / Capital Employed (Equity 13.0b + L.T.Debt 4.24b))
RoIC = 6.65% (NOPAT 1.45b / Invested Capital 21.7b)
WACC = 8.32% (E(20.4b)/V(28.2b) * Re(10.25%) + D(7.78b)/V(28.2b) * Rd(4.28%) * (1-Tc(0.24)))
Discount Rate = 10.25% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 66.04 | Cagr: 0.07%
[DCF] Terminal Value 77.97% ; FCFF base≈1.25b ; Y1≈1.44b ; Y5≈2.11b
[DCF] Fair Price = 45.18 (EV 31.8b - Net Debt 7.05b = Equity 24.7b / Shares 546.9m; r=8.35% [WACC [floored]]; 5y FCF grow 14.97% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.24 | # QB: 0
Revenue Correlation: 94.38 | Revenue CAGR: 0.59% | SUE: 1.19 | # QB: 1
EPS current Quarter (2026-09-30): EPS=1.04 | Chg30d=-2.61% | Revisions=-40% | Analysts=8
EPS current Year (2026-12-31): EPS=2.46 | Chg30d=-0.78% | Revisions=-18% | GrowthEPS=+14.8% | GrowthRev=+6.1%
EPS next Year (2027-12-31): EPS=2.77 | Chg30d=-4.85% | Revisions=-70% | GrowthEPS=+12.8% | GrowthRev=+4.7%
[Analyst] Revisions Ratio: -55% (up=3, down=14)